RNA interference-mediated suppression of TNF-α converting enzyme as an alternative anti-TNF-α therapy for rheumatoid arthritis-Reference-Cited by-同舟云学术

RNA interference-mediated suppression of TNF-α converting enzyme as an alternative anti-TNF-α therapy for rheumatoid arthritis

Published:2021-02 Issue: Volume:330 Page:1300-1312
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Song Yoonsung,Jo Sungsin,Chung Jee Young,Oh Younseo,Yoon Subin,Lee Young Lim,Kim Seong Su,Yang Jae-Hyuk,Jang Kiseok,Yang Chul-Su,Kim Tae-Hwan,Kim Yong-Hee

Funder

National Research Foundation of Korea

Ministry of Health and Welfare

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference54 articles.

1. Evolving concepts of rheumatoid arthritis;Firestein,2003

2. Targeting synovial neoangiogenesis in rheumatoid arthritis;Leblond,2017

3. Starving the synovium: angiogenesis and inflammation in rheumatoid arthritis;Firestein,1999

4. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases;Feldmann,2003

5. MMP profile in paired serum and synovial fluid samples of patients with rheumatoid arthritis;Tchetverikov,2004

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-Cell Multi-Dimensional data analysis reveals the role of ARL4C in driving rheumatoid arthritis progression and Macrophage polarization dynamics;International Immunopharmacology;2024-11

2. MiR-204/-211 double knockout exacerbates rheumatoid arthritis progression by promoting splenic inflammation;International Immunopharmacology;2024-10

3. Targeting Hepatic Cancer Stem Cells (CSCs) and Related Drug Resistance by Small Interfering RNA (siRNA);Cell Biochemistry and Biophysics;2024-07-26

4. Nanomedicines targeting activated immune cells and effector cells for rheumatoid arthritis treatment;Journal of Controlled Release;2024-07

5. ADAM17 variant causes hair loss via ubiquitin ligase TRIM47–mediated degradation;JCI Insight;2024-05-21